Cargando…
DELAFLOXACIN, A NOVEL FLUOROQUINOLONE ANTIBIOTIC WITH ACTIVITY AGAINST HOSPITAL-, COMMUNITY- AND LIVESTOCK- ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
Autores principales: | Maguire, Mollie, Moore, John E, Millar, B. Cherie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Ulster Medical Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907908/ https://www.ncbi.nlm.nih.gov/pubmed/33642636 |
Ejemplares similares
-
Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
por: Kocsis, Béla, et al.
Publicado: (2021) -
1588. Delafloxacin Activity Against Staphylococcus aureus with Reduced Susceptibility or Resistance to Methicillin, Vancomycin, Daptomycin, or Linezolid
por: Saravolatz, Louis D, et al.
Publicado: (2019) -
Livestock-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) as Causes of Human Infection and Colonization in Germany
por: Köck, Robin, et al.
Publicado: (2013) -
Livestock-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) in Purulent Subcutaneous Lesions of Farm Rabbits
por: Silva, Vanessa, et al.
Publicado: (2020) -
Prevalence and Antibiotic Susceptibility of Community-Associated Methicillin-Resistant Staphylococcus aureus in a Rural Area of India: Is MRSA Replacing Methicillin-Susceptible Staphylococcus aureus in the Community?
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2012)